Seoul Recap｜Biosyntech Shines at CPHI Korea 2026, Striving for New Cooperation across Asia?Pacific
CPHI Korea 2026 has successfully concluded at COEX, Seoul, South Korea. Suzhou Biosyntech showcased at Booth N30, presenting pharmaceutical intermediates, targeted?protein degrader intermediates, fluorinated fine chemicals, as well as full?range services including CRO/CDMO custom synthesis and in?house kg?to?ton scale?up manufacturing. During the exhibition, our business and technical teams had in?depth exchanges with clients from South Korea and broader Asia?Pacific regions. We discussed custom R&D, process scale?up and export cooperation, and secured multiple promising cooperation intentions, further strengthening our brand influence in the Asia?Pacific biopharmaceutical market.
The exhibition has come to an end, yet our cooperation journey continues. Going forward, we will keep focusing on fine pharmaceutical chemicals. By delivering high?quality products and professional services for global partners, we aim to jointly explore overseas markets and pursue win?win opportunities.
